Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FFP104 in moderate to severely active Crohn's disease
NCT02465944Phase 2Unknown
- Sponsor
- Fast Forward Pharmaceuticals BV
- Start
- Jan 2016
- Primary completion
- Aug 2017
- Countries
- 2
01
Overview
A Phase 2 trial of FFP104 in Crohn's disease, sponsored by Fast Forward Pharmaceuticals BV. Status: unknown.
02
Drugs
FFP104
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02465944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02465944.